01—Abstract
Summary
Summary of the 8-K filed May 21, 2026. Cited figures are marked; the original filing is the authoritative source.
Omega Healthcare Investors, Inc. (NYSE: OHI) announced a planned leadership transition in an 8-K filed May 21, 2026.
Chief Executive Officer C. Taylor Pickett's employment and Board position will terminate effective October 1, 2026, and Matthew P. Gourmand, the Company's President, will become President and Chief Executive Officer on that date; Gourmand is also expected to join the Board.
Chief Financial Officer Robert O. Stephenson's employment will terminate effective August 1, 2026, when Neal A. Ballew, the Senior Vice President and Chief Accounting Officer, becomes Chief Financial Officer and Lucas M.
Golem, Vice President of Financial Reporting, becomes Chief Accounting Officer. The Board described the changes as reflecting upcoming retirement plans and long-term succession planning. Both departing executives entered into Transition Agreements and Release, and Consulting Agreements.
Pickett will receive his 2026 short-term incentive earned on an un-prorated basis, equity awards vesting through December 31, 2029 on an un-prorated basis, COBRA-related health premium coverage for up to 18 months, and a $20,000a monthly consulting fee through October 1, 2027 (extendable at the Company's option to April 1, 2028). Stephenson receives payments and benefits tied to a termination without cause under his employment agreement, the 2026 short-term incentive on an un-prorated basis, equity vesting through December 31, 2029 on an un-prorated basis, and a $12,000 monthly consulting fee through August 1, 2027 (extendable to February 1, 2028). All benefits are conditioned on general releases and continued covenant compliance.
The accompanying press release (Exhibit 99.1) quotes management describing the transition as a multi-year succession plan. It states that Stephenson leaves the Company as an investment-grade credit with a well-laddered maturity schedule and leverage near all-time lows, and it cites a total shareholder return of over 10,000%b during Pickett's 25 years as CEO.
02—Key points
Key Highlights
- CEO change: C. Taylor Pickett's employment and Board position end October 1, 2026; Matthew P. Gourmand, currently President, becomes President and CEO that day.
- CFO change: Robert O. Stephenson's employment ends August 1, 2026; Neal A. Ballew, currently Senior VP and Chief Accounting Officer, becomes CFO.
- Lucas M. Golem, Vice President of Financial Reporting, succeeds Ballew as Chief Accounting Officer effective August 1, 2026.
- Pickett receives a $20,000 monthly consulting fee through October 1, 2027, extendable to April 1, 2028, and un-prorated equity vesting through December 31, 2029.
- Stephenson receives a $12,000 monthly consulting fee through August 1, 2027, extendable to February 1, 2028, and un-prorated equity vesting through December 31, 2029.
- Both departures are conditioned on general releases of claims and continued compliance with post-termination covenants.
- The press release describes Stephenson's stewardship as leaving the Company an investment-grade credit with leverage near all-time lows.
03—Questions
Frequently Asked Questions
Who will lead Omega Healthcare Investors after the transition?
Matthew P. Gourmand, currently President, will become President and Chief Executive Officer effective October 1, 2026, and the Board intends to appoint him to the Board on that date. Neal A. Ballew, currently Senior Vice President and Chief Accounting Officer, will become Chief Financial Officer effective August 1, 2026.
Why are the executives leaving?
The Board and the departing executives mutually agreed to the terminations, which the filing links to upcoming retirement plans and long-term leadership succession planning. The press release describes the changes as the culmination of a carefully managed, multi-year succession plan.
What compensation and transition terms apply to the departing executives?
Pickett will receive his 2026 short-term incentive earned on an un-prorated basis, previously granted equity vesting through December 31, 2029 on an un-prorated basis, employer-paid COBRA premiums for up to 18 months, and a $20,000 monthly consulting fee. Stephenson will receive termination-without-cause benefits under his employment agreement, his 2026 short-term incentive on an un-prorated basis, equity vesting through December 31, 2029 on an un-prorated basis, and a $12,000 monthly consulting fee. Both sets of benefits are conditioned on general releases and continued covenant compliance.
Will the departing executives remain involved with the Company?
Yes. Pickett will provide consulting and advisory services through October 1, 2027, extendable at the Company's option to April 1, 2028. Stephenson will provide such services through August 1, 2027, extendable at the Company's option to February 1, 2028.
04—Continue